Alyeska Investment Group, L.P. 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:54 pm Sale |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
Alyeska Investment Group, L.P. | 0 0.000% |
-84,605 (Position Closed) |
Filing |
| 2021-02-16 11:21 am Purchase |
2020-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
Alyeska Investment Group, L.P. | 84,605 6.800% |
84,605 (New Position) |
Filing |